Nome |
# |
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA, file e27ce431-ddf4-2581-e053-d805fe0acbaa
|
598
|
Practical treatment using mitotane for adrenocortical carcinoma., file e27ce426-f6c1-2581-e053-d805fe0acbaa
|
568
|
COVID-19 infection: ACE2, pregnancy and preeclampsia, file e27ce430-fd6f-2581-e053-d805fe0acbaa
|
486
|
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce426-eda7-2581-e053-d805fe0acbaa
|
478
|
Management of adjuvant mitotane therapy following resection of adrenal cancer., file e27ce429-8e03-2581-e053-d805fe0acbaa
|
446
|
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients., file e27ce429-f428-2581-e053-d805fe0acbaa
|
335
|
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children, file e27ce42c-0323-2581-e053-d805fe0acbaa
|
314
|
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients., file e27ce429-e7ed-2581-e053-d805fe0acbaa
|
281
|
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma, file bc58b4c0-d211-4567-a298-33d9469bb163
|
262
|
EFFECT OF SEASONS ON FOUR ANTI-EPILEPTIC DRUGS PLASMA LEVELS, file e27ce431-c5b3-2581-e053-d805fe0acbaa
|
246
|
GENDER ANALYSIS ON COVID-19 DATA IN PIEMONTE: THE VIRUS PREFERS MEN, file e27ce431-ed70-2581-e053-d805fe0acbaa
|
240
|
Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns., file e27ce42d-243f-2581-e053-d805fe0acbaa
|
213
|
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION., file e27ce426-e3d4-2581-e053-d805fe0acbaa
|
192
|
Gender differences in five different drug pharmacokinetics, file d74e3900-88cf-452d-b7c3-28e8aa36acc8
|
186
|
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant., file e27ce429-fcab-2581-e053-d805fe0acbaa
|
140
|
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file e27ce42c-70ef-2581-e053-d805fe0acbaa
|
132
|
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma, file 6230cd5b-b82f-4394-916c-496a213cf767
|
118
|
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity, file e27ce432-7fb6-2581-e053-d805fe0acbaa
|
108
|
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane., file e27ce42a-1a58-2581-e053-d805fe0acbaa
|
101
|
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection, file e27ce42c-2693-2581-e053-d805fe0acbaa
|
100
|
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells, file e27ce42c-e0c3-2581-e053-d805fe0acbaa
|
87
|
“New standardised procedure to extract glyphosate and aminomethylphosphonic acid (ampa) from organic and inorganic matrices: toward a practical kit for hplc-uv detection”, file 829a24dd-b2d0-4064-8e73-8b49c1fe1ec6
|
83
|
NURR1 deficiency is associated to ADHD-like phenotypes in mice, file e27ce42f-89f7-2581-e053-d805fe0acbaa
|
83
|
Gender analysis on COVID-19 data in piemonte: the virus prefers men, file 4f7412a7-0472-4f35-8d4f-7590526df2e5
|
77
|
Development and validation of an HPLC method for orotic acid and orotidine 5’-monophosphate detection in human plasma and urine, file c6e92b15-3c78-4cf9-8d60-fa76ae8f9149
|
77
|
Effect of seasons on four anti-epileptic drugs plasma levels, file bbd12e9f-1231-49f4-aca0-b3078799dc8e
|
72
|
A convenient method for extraction and analysis with high-pressure liquid chromatography of cathecholamine neurotransmitters in plasma and brain samples of mice, file 47be7b0f-324a-45dd-9ecc-36dedff7f5bf
|
67
|
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness, file e27ce427-f197-2581-e053-d805fe0acbaa
|
65
|
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring, file e27ce432-7fb8-2581-e053-d805fe0acbaa
|
64
|
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity, file e27ce435-2d5c-2581-e053-d805fe0acbaa
|
53
|
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma, file e27ce431-615f-2581-e053-d805fe0acbaa
|
52
|
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization, file e27ce427-0982-2581-e053-d805fe0acbaa
|
45
|
Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: A multicenter ENSAT study, file e27ce430-0f45-2581-e053-d805fe0acbaa
|
42
|
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats., file e27ce429-f922-2581-e053-d805fe0acbaa
|
41
|
DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR OROTIC ACID AND OROTIDINE 5’-MONOPHOSPHATE DETECTION IN HUMAN
PLASMA AND URINE, file e27ce432-284a-2581-e053-d805fe0acbaa
|
26
|
The influence of sex, gender and age on COVID-19 data in the Piedmont region: the virus prefers men, file e27ce435-2946-2581-e053-d805fe0acbaa
|
18
|
La Medicina delle differenze. Storie di donne, uomini e discriminazioni., file e27ce431-0ddc-2581-e053-d805fe0acbaa
|
17
|
NURR1-deficient mice have age- and sex-specific behavioral phenotypes, file 8a101ff5-85a9-479e-80c3-25823d4f4681
|
12
|
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes, file e27ce42b-fd4b-2581-e053-d805fe0acbaa
|
10
|
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma, file 2b1a2a94-ae71-42dc-b83e-849198b18acb
|
9
|
The Influence of sex, gender, and age on COVID-19 data in the Piedmont Region (Northwest Italy): the virus prefers men, file 82839156-51d9-4aea-8b68-2586a0949857
|
9
|
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children, file a8c804c5-7365-42d1-ad56-c4f1fca0ab19
|
8
|
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants, file e27ce435-2ab2-2581-e053-d805fe0acbaa
|
7
|
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file 46675b6e-6c0b-445b-bf84-7164b823926a
|
6
|
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia, file e27ce428-c622-2581-e053-d805fe0acbaa
|
6
|
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children, file e27ce42b-eb8d-2581-e053-d805fe0acbaa
|
6
|
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma, file e27ce42b-ee75-2581-e053-d805fe0acbaa
|
6
|
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma, file f50fd863-420d-4151-8d79-a9a350494107
|
6
|
A convenient method for extraction and analysis with High-Pressure Liquid Chromatography of catecholamine neurotransmitters in plasma and brain samples of mice, file c336ee78-f75b-426d-9d66-51b444831308
|
5
|
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients., file e27ce429-f91b-2581-e053-d805fe0acbaa
|
5
|
"Procedimento per determinare glifosato e acido aminometilfosfonico in un campione", file e27ce432-15a7-2581-e053-d805fe0acbaa
|
5
|
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane., file e27ce426-e4db-2581-e053-d805fe0acbaa
|
4
|
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness., file e27ce428-b2ce-2581-e053-d805fe0acbaa
|
3
|
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats., file e27ce429-f1b0-2581-e053-d805fe0acbaa
|
3
|
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia, file e27ce42a-ed50-2581-e053-d805fe0acbaa
|
3
|
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children, file e27ce42c-1042-2581-e053-d805fe0acbaa
|
3
|
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients, file e27ce42d-5e98-2581-e053-d805fe0acbaa
|
3
|
Pharmacogenetic of voriconazole antifungal agent in pediatric patients, file e27ce42d-7320-2581-e053-d805fe0acbaa
|
3
|
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients, file e27ce42d-94fe-2581-e053-d805fe0acbaa
|
3
|
Correlated quantification using microbiological and electrochemical assays for roxithromycin determination in biological and pharmaceutical samples, file e27ce432-210a-2581-e053-d805fe0acbaa
|
3
|
Age and Sex-Related Differences in Teicoplanine Isoform Concentrations in SARS-CoV-2 Patients, file 870a3e47-4d32-4696-98f5-4c5004cc73ed
|
2
|
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study, file bb75f268-5a8c-4f11-a40e-66aea8a601cd
|
2
|
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization, file e27ce427-0923-2581-e053-d805fe0acbaa
|
2
|
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients., file e27ce429-e7f4-2581-e053-d805fe0acbaa
|
2
|
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant., file e27ce429-f920-2581-e053-d805fe0acbaa
|
2
|
Deferasirox AUC efficacy cutoff and role of pharmacogenetics, file e27ce42a-907d-2581-e053-d805fe0acbaa
|
2
|
Role of pharmacogenetics on deferasirox AUC and efficacy, file e27ce42a-c6a0-2581-e053-d805fe0acbaa
|
2
|
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce42a-ee0b-2581-e053-d805fe0acbaa
|
2
|
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients, file e27ce42b-ab62-2581-e053-d805fe0acbaa
|
2
|
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients, file e27ce42b-c5f3-2581-e053-d805fe0acbaa
|
2
|
Clinical relevance of deferasirox trough levels in β-thalassemia patients, file e27ce42c-5f9e-2581-e053-d805fe0acbaa
|
2
|
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients, file e27ce430-ae22-2581-e053-d805fe0acbaa
|
2
|
Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns., file e27ce432-4f88-2581-e053-d805fe0acbaa
|
2
|
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children, file e27ce432-5075-2581-e053-d805fe0acbaa
|
2
|
GENDER-SPECIFIC SIDE EFFECTS OF CHEMOTHERAPY IN PANCREATIC CANCER PATIENTS, file e27ce434-321a-2581-e053-d805fe0acbaa
|
2
|
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome, file e27ce426-b3f0-2581-e053-d805fe0acbaa
|
1
|
In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation, file e27ce426-d2d1-2581-e053-d805fe0acbaa
|
1
|
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment, file e27ce42a-e7b9-2581-e053-d805fe0acbaa
|
1
|
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children, file e27ce42c-091c-2581-e053-d805fe0acbaa
|
1
|
Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?, file ff74c4b7-3fdf-4774-9a37-bcfd1b859e78
|
1
|
Totale |
6.676 |